Researchers at San Diego State University and Michigan State University are shedding new light on how viruses meticulously ...

As aging progresses, the quality of DNA and proteins inside cells declines, which is known to be the cause of various ...

Dawnzera is the first and so far only RNA-targeting therapy approved as a prophylactic treatment for hereditary angioedema ...

Sarepta is facing a number of issues currently, including platform-level safety concerns, management credibility issues, etc.

In 1957, just four years after Francis Crick and other scientists solved the riddle of DNA’s structure—the now famous double ...

The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...

The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved ...

In June, the monoclonal antibody garadacimab (Andembry) was approved for prevention of HAE attacks at a dose of once monthly ...

Single-cell proteomics with RNA sequencing uncover hidden gene expression dynamics in stem cell differentiation.

The collaboration will explore RNA-based small molecule drug candidates aimed at neurological conditions where existing ...

A new nanotube-based RNA delivery system boosts plant regeneration by switching off a molecule that blocks shoot growth, ...